SMVIX
Price
$22.73
Change
-$4.77 (-17.35%)
Updated
Dec 17 closing price
VSIAX
Price
$88.58
Change
-$1.09 (-1.22%)
Updated
Dec 17 closing price
Ad is loading...

SMVIX vs VSIAX

Header iconSMVIX vs VSIAX Comparison
Open Charts SMVIX vs VSIAXBanner chart's image
SEI Small Cap Value I (SIMT)
Price$22.73
Change-$4.77 (-17.35%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$88.58
Change-$1.09 (-1.22%)
VolumeN/A
CapitalizationN/A
SMVIX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SMVIX vs. VSIAX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMVIX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. SMVIX (312M). VSIAX pays higher dividends than SMVIX: VSIAX (2.01) vs SMVIX (0.96). SMVIX was incepted earlier than VSIAX: SMVIX (23 years) vs VSIAX (13 years). SMVIX is a more actively managed with annual turnover of: 39.00 vs. VSIAX (16.00). VSIAX has a lower initial minimum investment than SMVIX: VSIAX (3000) vs SMVIX (100000). SMVIX (16.28) and VSIAX (16.23) have marching annual gain over last year. VSIAX return over 5 years is better than : 52.83 vs. SMVIX (30.20).
SMVIXVSIAXSMVIX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years13 years-
Gain YTD13.79415.03192%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets312M63B0%
Annual Yield % from dividends0.962.0147%
Returns for 1 year16.2816.23100%
Returns for 3 years12.5820.6761%
Returns for 5 years30.2052.8357%
Returns for 10 years26.97105.6526%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics